Table 4. Comparison of LAIV and TIV on hospitalizations and medically significant wheezing (19).

Adverse Reaction	Age Group	LAIV	TIV Controli
All cause hospitalizationsii	6-23 months (n=3967)	4.2%	3.2%
	24-59 months (n=4385)	2.1%	2.5%
Wheezingiii	6-23 months (n=3967)	5.9%	3.8%iv
	24-59 months (n=4385)	2.1%	2.5%

ⁱ Injectable influenza vaccine made by Sanofi Pasteur inc

ⁱⁱ from randomization through 180 days post last vaccination

ⁱⁱⁱ wheezing requiring bronchodilator therapy or with significant respiratory symptoms evaluation from randomization through 42 days post last vaccination

^iv statistically significant difference, (95% CI: 7.2-3.38)